AG˹ٷ

STOCK TITAN

[Form 4] Cencora, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Cencora, Inc. (COR) � Form 4 insider transaction

Executive Vice President Silvana Battaglia reported the sale of 4,077 common shares on 18-Jun-2025 at an average price of $297.405 per share. Following the transaction, Battaglia’s direct holding stands at 11,296.889 shares. No derivative securities were involved, and no Rule 10b5-1 plan was indicated. The filing was signed on 20-Jun-2025.

Cencora, Inc. (COR) � Transazione interna Form 4

La Vicepresidente Esecutiva Silvana Battaglia ha comunicato la vendita di 4.077 azioni ordinarie il 18 giugno 2025 ad un prezzo medio di 297,405 $ per azione. Dopo l'operazione, la partecipazione diretta di Battaglia ammonta a 11.296,889 azioni. Non sono stati coinvolti titoli derivati e non è stato indicato alcun piano ai sensi della Regola 10b5-1. La comunicazione è stata firmata il 20 giugno 2025.

Cencora, Inc. (COR) � Transacción interna Formulario 4

La Vicepresidenta Ejecutiva Silvana Battaglia informó la venta de 4,077 acciones comunes el 18 de junio de 2025 a un precio promedio de $297.405 por acción. Tras la transacción, la tenencia directa de Battaglia es de 11,296.889 acciones. No se involucraron valores derivados y no se indicó ningún plan bajo la Regla 10b5-1. La presentación fue firmada el 20 de junio de 2025.

Cencora, Inc. (COR) � Form 4 내부� 거래 보고

붶사장 실바� 바탈리아가 2025� 6� 18일에 4,077� 보통� 매각� 평균 주당 $297.405 가격에 보고했습니다. 거래 � 바탈리아� 직접 보유 주식 수는 11,296.889�입니�. 파생상품은 포함되지 않았으며, Rule 10b5-1 계획� 명시되지 않았습니�. 신고서는 2025� 6� 20일에 서명되었습니�.

Cencora, Inc. (COR) � Transaction d’initié Formulaire 4

La Vice-Présidente Exécutive Silvana Battaglia a déclaré la vente de 4 077 actions ordinaires le 18 juin 2025 à un prix moyen de 297,405 $ par action. Suite à cette transaction, la détention directe de Battaglia s’élève à 11 296,889 actions. Aucun titre dérivé n’a été impliqué et aucun plan selon la règle 10b5-1 n’a été indiqué. Le dépôt a été signé le 20 juin 2025.

Cencora, Inc. (COR) � Insider-Transaktion Form 4

Die Executive Vice President Silvana Battaglia meldete den Verkauf von 4.077 Stammaktien am 18. Juni 2025 zu einem durchschnittlichen Preis von 297,405 $ pro Aktie. Nach der Transaktion hält Battaglia direkt 11.296,889 Aktien. Es waren keine Derivate beteiligt, und es wurde kein Rule 10b5-1-Plan angegeben. Die Einreichung wurde am 20. Juni 2025 unterzeichnet.

Positive
  • Executive retains 11,296.889 shares, preserving meaningful equity alignment with shareholders
Negative
  • Sale of 4,077 shares at $297.405 may signal reduced short-term confidence

Insights

TL;DR � EVP sold ~4k shares; modest size, mildly negative signal.

The sale represents roughly 26% of Battaglia’s directly held shares prior to the trade (assuming post-sale balance of 11.3k). While insider sales can indicate diminished confidence or personal liquidity needs, the volume is small relative to Cencora’s daily trading volume and market capitalization, so market impact should be limited. No derivative exercise suggests it was not part of option management. Overall, it is a slightly bearish governance signal but not a material fundamental event.

TL;DR � Routine Section 16 filing; governance compliant, impact neutral.

The Form 4 was timely filed within two business days, reflecting good compliance. There is no indication of a 10b5-1 trading plan, so the discretionary sale could attract investor scrutiny, yet the executive retains a meaningful equity stake (>11k shares), maintaining alignment with shareholders. From a governance perspective, the event is procedurally normal and low-impact.

Cencora, Inc. (COR) � Transazione interna Form 4

La Vicepresidente Esecutiva Silvana Battaglia ha comunicato la vendita di 4.077 azioni ordinarie il 18 giugno 2025 ad un prezzo medio di 297,405 $ per azione. Dopo l'operazione, la partecipazione diretta di Battaglia ammonta a 11.296,889 azioni. Non sono stati coinvolti titoli derivati e non è stato indicato alcun piano ai sensi della Regola 10b5-1. La comunicazione è stata firmata il 20 giugno 2025.

Cencora, Inc. (COR) � Transacción interna Formulario 4

La Vicepresidenta Ejecutiva Silvana Battaglia informó la venta de 4,077 acciones comunes el 18 de junio de 2025 a un precio promedio de $297.405 por acción. Tras la transacción, la tenencia directa de Battaglia es de 11,296.889 acciones. No se involucraron valores derivados y no se indicó ningún plan bajo la Regla 10b5-1. La presentación fue firmada el 20 de junio de 2025.

Cencora, Inc. (COR) � Form 4 내부� 거래 보고

붶사장 실바� 바탈리아가 2025� 6� 18일에 4,077� 보통� 매각� 평균 주당 $297.405 가격에 보고했습니다. 거래 � 바탈리아� 직접 보유 주식 수는 11,296.889�입니�. 파생상품은 포함되지 않았으며, Rule 10b5-1 계획� 명시되지 않았습니�. 신고서는 2025� 6� 20일에 서명되었습니�.

Cencora, Inc. (COR) � Transaction d’initié Formulaire 4

La Vice-Présidente Exécutive Silvana Battaglia a déclaré la vente de 4 077 actions ordinaires le 18 juin 2025 à un prix moyen de 297,405 $ par action. Suite à cette transaction, la détention directe de Battaglia s’élève à 11 296,889 actions. Aucun titre dérivé n’a été impliqué et aucun plan selon la règle 10b5-1 n’a été indiqué. Le dépôt a été signé le 20 juin 2025.

Cencora, Inc. (COR) � Insider-Transaktion Form 4

Die Executive Vice President Silvana Battaglia meldete den Verkauf von 4.077 Stammaktien am 18. Juni 2025 zu einem durchschnittlichen Preis von 297,405 $ pro Aktie. Nach der Transaktion hält Battaglia direkt 11.296,889 Aktien. Es waren keine Derivate beteiligt, und es wurde kein Rule 10b5-1-Plan angegeben. Die Einreichung wurde am 20. Juni 2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Battaglia Silvana

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 S 4,077 D $297.405 11,296.889 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Silvana Battaglia 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Cencora (COR) shares did EVP Silvana Battaglia sell?

She sold 4,077 common shares on 18-Jun-2025.

At what price were the COR shares sold?

The shares were sold at an average price of $297.405 per share.

How many COR shares does the executive own after the sale?

Battaglia now owns 11,296.889 shares directly.

Did the Form 4 filing mention any derivative security transactions?

No, no derivative securities were acquired or disposed of in this filing.

Was the transaction conducted under a Rule 10b5-1 trading plan?

The form does not indicate that the sale was made under a 10b5-1 plan.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

57.48B
183.55M
6.85%
92.69%
3.58%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
United States
CONSHOHOCKEN